🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Investigational Drug Gaining Popularity Online

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are encouraged to message these profiles privately for supplier links, while also receiving promotional offers.

Thriving Trade on Social Networks

Separately, a robust trade exists on Telegram, where communities with thousands of participants share “before and after” photos, injection guides and assertions of rapid UK delivery. Sellers promote the drug there before directing customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Professionals Express Concerns

However, physicians and chemists have cautions that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could lead to individuals injecting products of uncertain source.

Several experts said the popularity for the experimental drug could be connected to the rising price of approved weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.

Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach medicines, advertising, and customer regulations, potentially leading to penalties, prosecution or prison.

Service Reaction and Material Removal

Based on the social media company, the platform has removed problematic content and banned related hashtags and query recommendations. The organization stated it was dedicated to maintaining the service secure and investing in strengthening compliance measures.

Digital Trading Activities

Investigations also discovered communities with up to nine thousand participants selling the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up channels with numerous of members, filled with photos of slimming results, glowing testimonials and step-by-step guides for preparing or injecting at home.

After moments of entering one community, a vendor posted contact information, where the majority of transactions occur. The vendor sent an instruction manual and promised shipping within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about weight, medical conditions or past usage.

Product Information and Costs

Within these communities, posts show black plastic parcels with Royal Mail stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or pre-filled pens usually priced at £160 for 20 milligrams. When asked how much time a injector should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A representative for Telegram stated it actively moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering materials they can’t verify. Although the research behind retatrutide is valid, these online versions may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent price rises for authorized slimming medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake injections are extremely risky. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.

Her staff has previously encountered patients injured by personal administration from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company experimental substance not yet approved … may subject users to possibly significant health risks”.